AllianceBernstein’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-574,974
| Closed | -$10.3M | – | 3251 |
|
|
2020
Q2 | $10.3M | Buy |
574,974
+474,074
| +470% | +$6.59M | 0.01% | 991 |
|
|
2020
Q1 | $719K | Sell |
100,900
-1,700
| -2% | -$21.2K | ﹤0.01% | 2185 |
|
|
2019
Q4 | $2.45M | Buy |
102,600
+7,000
| +7% | +$193K | ﹤0.01% | 1849 |
|
|
2019
Q3 | $2.56M | Buy |
95,600
+1,800
| +2% | +$50.5K | ﹤0.01% | 1781 |
|
|
2019
Q2 | $2.54M | Hold |
93,800
| – | – | ﹤0.01% | 1824 |
|
|
2019
Q1 | $3.25M | Buy |
93,800
+665
| +0.7% | +$19.2K | ﹤0.01% | 1628 |
|
|
2018
Q4 | $1.82M | Sell |
93,135
-1,225
| -1% | -$25.2K | ﹤0.01% | 1880 |
|
|
2018
Q3 | $2.51M | Hold |
94,360
| – | – | ﹤0.01% | 1784 |
|
|
2018
Q2 | $3.56M | Sell |
94,360
-72,000
| -43% | -$2.75M | ﹤0.01% | 1488 |
|
|
2018
Q1 | $5.43M | Buy |
166,360
+90,000
| +118% | +$3.95M | ﹤0.01% | 1178 |
|
|
2017
Q4 | $3.72M | Sell |
76,360
-26,010
| -25% | -$1.32M | ﹤0.01% | 1406 |
|
|
2017
Q3 | $5.53M | Sell |
102,370
-2,780
| -3% | -$163K | ﹤0.01% | 1169 |
|
|
2017
Q2 | $5.91M | Sell |
105,150
-266,223
| -72% | -$10.7M | ﹤0.01% | 1129 |
|
|
2017
Q1 | $14.6M | Buy |
371,373
+29,090
| +8% | +$926K | 0.01% | 845 |
|
|
2016
Q4 | $7.68M | Hold |
342,283
| – | – | 0.01% | 1000 |
|
|
2016
Q3 | $7.77M | Hold |
342,283
| – | – | 0.01% | 961 |
|
|
2016
Q2 | $8.08M | Hold |
342,283
| – | – | 0.01% | 921 |
|
|
2016
Q1 | $6.98M | Hold |
342,283
| – | – | 0.01% | 938 |
|
|
2015
Q4 | $17.6M | Sell |
342,283
-15
| -0% | -$727 | 0.02% | 745 |
|
|
2015
Q3 | $14.6M | Buy |
342,298
+475
| +0.1% | +$22.9K | 0.01% | 788 |
|
|
2015
Q2 | $15.6M | Buy |
341,823
+11,200
| +3% | +$451K | 0.01% | 799 |
|
|
2015
Q1 | $12.6M | Buy |
330,623
+3,800
| +1% | +$131K | 0.01% | 855 |
|
|
2014
Q4 | $9.26M | Hold |
326,823
| – | – | 0.01% | 908 |
|
|
2014
Q3 | $8.26M | Sell |
326,823
-26,900
| -8% | -$709K | 0.01% | 926 |
|
|
2014
Q2 | $10.3M | Buy |
353,723
+14,366
| +4% | +$348K | 0.01% | 877 |
|
|
2014
Q1 | $8.79M | Sell |
339,357
-453,500
| -57% | -$12.1M | 0.01% | 903 |
|
|
2013
Q4 | $20.4M | Buy |
792,857
+771,123
| +3,548% | +$18.7M | 0.02% | 658 |
|
|
2013
Q3 | $581K | Buy |
21,734
+10,490
| +93% | +$250K | ﹤0.01% | 2397 |
|
|
2013
Q2 | $276K | Buy |
+11,244
| New | +$223K | ﹤0.01% | 2743 |
|
AllianceBernstein's PTLA Position: Q3 2020 in Review
AllianceBernstein sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 574,974 shares — an estimated $10.3M sold.
AllianceBernstein first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $20.4M in Q4 2013. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- AllianceBernstein reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- AllianceBernstein sold 574,974 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10.3M.
- AllianceBernstein first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
- AllianceBernstein's Portola Pharmaceuticals, Inc. position peaked at $20.4M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on AllianceBernstein's 13F filing for Q3 2020, filed 12 Nov 2020.